Preferred study design for RSABE [Design Issues]

posted by Prasad Tata – 2013-01-04 16:14 (4925 d 18:19 ago) – Posting: # 9784
Views: 3,942

I am looking at diffeent study designs for the Bioequivalence trials. When applying for scaled bioequivalence which study design is superior and gives control over the 90% CI for a highly variable drug.1) 3-way cross over (TRR, RTR, RRT) or 4-way cross over (RRTT, RTRT etc.)


Any guidance with references or right examples will greatly help me.

Prasad Tata


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
244 visitors (0 registered, 244 guests [including 15 identified bots]).
Forum time: 11:34 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5